Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 1
1952 1
1953 1
1954 1
1955 1
1959 1
1964 1
1969 1
1972 1
1977 2
1979 1
1981 1
1982 1
1984 1
1986 1
1987 1
1988 1
1989 2
1990 2
1991 2
1992 2
1993 5
1994 3
1995 3
1996 3
1997 4
1998 6
1999 4
2000 11
2001 11
2002 10
2003 7
2004 9
2005 12
2006 7
2007 13
2008 16
2009 15
2010 10
2011 12
2012 19
2013 23
2014 39
2015 68
2016 64
2017 59
2018 57
2019 43
2020 35
2021 51
2022 50
2023 49
2024 48

Text availability

Article attribute

Article type

Publication date

Search Results

736 results

Results by year

Filters applied: . Clear all
Page 1
Microplastics and Nanoplastics in Atheromas and Cardiovascular Events.
Marfella R, Prattichizzo F, Sardu C, Fulgenzi G, Graciotti L, Spadoni T, D'Onofrio N, Scisciola L, La Grotta R, Frigé C, Pellegrini V, Municinò M, Siniscalchi M, Spinetti F, Vigliotti G, Vecchione C, Carrizzo A, Accarino G, Squillante A, Spaziano G, Mirra D, Esposito R, Altieri S, Falco G, Fenti A, Galoppo S, Canzano S, Sasso FC, Matacchione G, Olivieri F, Ferraraccio F, Panarese I, Paolisso P, Barbato E, Lubritto C, Balestrieri ML, Mauro C, Caballero AE, Rajagopalan S, Ceriello A, D'Agostino B, Iovino P, Paolisso G. Marfella R, et al. Among authors: esposito r. N Engl J Med. 2024 Mar 7;390(10):900-910. doi: 10.1056/NEJMoa2309822. N Engl J Med. 2024. PMID: 38446676 Free PMC article.
Acute pharyngitis in children and adults: descriptive comparison of current recommendations from national and international guidelines and future perspectives.
Pellegrino R, Timitilli E, Verga MC, Guarino A, Iacono ID, Scotese I, Tezza G, Dinardo G, Riccio S, Pellizzari S, Iavarone S, Lorenzetti G, Simeone G, Bergamini M, Donà D, Pierantoni L, Garazzino S, Esposito S, Venturini E, Gattinara GC, Lo Vecchio A, Marseglia GL, Di Mauro G, Principi N, Galli L, Chiappini E; Other members of the Italian Panel for the Management of Acute Pharyngitis in Children. Pellegrino R, et al. Among authors: esposito s. Eur J Pediatr. 2023 Dec;182(12):5259-5273. doi: 10.1007/s00431-023-05211-w. Epub 2023 Oct 11. Eur J Pediatr. 2023. PMID: 37819417 Free PMC article. Review.
An antibiotic course of 10 days is recommended if the prevention of ARF is the primary goal; conversely, some guidelines suggest a course of 5-7 days, assuming the symptomatic cure is the goal of treatment. Penicillin V and amoxicillin are the first-line options. In the ca …
An antibiotic course of 10 days is recommended if the prevention of ARF is the primary goal; conversely, some guidelines suggest a course of …
Guideline for the management of acute sore throat.
ESCMID Sore Throat Guideline Group; Pelucchi C, Grigoryan L, Galeone C, Esposito S, Huovinen P, Little P, Verheij T. ESCMID Sore Throat Guideline Group, et al. Among authors: esposito s. Clin Microbiol Infect. 2012 Apr;18 Suppl 1:1-28. doi: 10.1111/j.1469-0691.2012.03766.x. Clin Microbiol Infect. 2012. PMID: 22432746 Free article.
If antibiotics are indicated, penicillin V, twice or three times daily for 10 days is recommended. At the present, there is no evidence enough that indicates shorter treatment length....
If antibiotics are indicated, penicillin V, twice or three times daily for 10 days is recommended. At the present, there is no eviden …
The Tumor Profiler Study: integrated, multi-omic, functional tumor profiling for clinical decision support.
Irmisch A, Bonilla X, Chevrier S, Lehmann KV, Singer F, Toussaint NC, Esposito C, Mena J, Milani ES, Casanova R, Stekhoven DJ, Wegmann R, Jacob F, Sobottka B, Goetze S, Kuipers J, Sarabia Del Castillo J, Prummer M, Tuncel MA, Menzel U, Jacobs A, Engler S, Sivapatham S, Frei AL, Gut G, Ficek J, Miglino N; Tumor Profiler Consortium; Aebersold R, Bacac M, Beerenwinkel N, Beisel C, Bodenmiller B, Dummer R, Heinzelmann-Schwarz V, Koelzer VH, Manz MG, Moch H, Pelkmans L, Snijder B, Theocharides APA, Tolnay M, Wicki A, Wollscheid B, Rätsch G, Levesque MP. Irmisch A, et al. Among authors: esposito c. Cancer Cell. 2021 Mar 8;39(3):288-293. doi: 10.1016/j.ccell.2021.01.004. Epub 2021 Jan 21. Cancer Cell. 2021. PMID: 33482122 Free article.
Atypical KRASG12R Mutant Is Impaired in PI3K Signaling and Macropinocytosis in Pancreatic Cancer.
Hobbs GA, Baker NM, Miermont AM, Thurman RD, Pierobon M, Tran TH, Anderson AO, Waters AM, Diehl JN, Papke B, Hodge RG, Klomp JE, Goodwin CM, DeLiberty JM, Wang J, Ng RWS, Gautam P, Bryant KL, Esposito D, Campbell SL, Petricoin EF 3rd, Simanshu DK, Aguirre AJ, Wolpin BM, Wennerberg K, Rudloff U, Cox AD, Der CJ. Hobbs GA, et al. Among authors: esposito d. Cancer Discov. 2020 Jan;10(1):104-123. doi: 10.1158/2159-8290.CD-19-1006. Epub 2019 Oct 24. Cancer Discov. 2020. PMID: 31649109 Free PMC article.
We evaluated whether KRAS(G12R) is functionally distinct from the more common KRAS(G12D)- or KRAS(G12V)-mutant proteins (KRAS(G12D/V)). We found that KRAS(G12D/V) but not KRAS(G12R) drives macropinocytosis and that MYC is essential for macropinocytosis in KRAS(G12D/ …
We evaluated whether KRAS(G12R) is functionally distinct from the more common KRAS(G12D)- or KRAS(G12V)-mutant proteins (KRAS(G12D/V) …
Choice of template delivery mitigates the genotoxic risk and adverse impact of editing in human hematopoietic stem cells.
Ferrari S, Jacob A, Cesana D, Laugel M, Beretta S, Varesi A, Unali G, Conti A, Canarutto D, Albano L, Calabria A, Vavassori V, Cipriani C, Castiello MC, Esposito S, Brombin C, Cugnata F, Adjali O, Ayuso E, Merelli I, Villa A, Di Micco R, Kajaste-Rudnitski A, Montini E, Penaud-Budloo M, Naldini L. Ferrari S, et al. Among authors: esposito s. Cell Stem Cell. 2022 Oct 6;29(10):1428-1444.e9. doi: 10.1016/j.stem.2022.09.001. Cell Stem Cell. 2022. PMID: 36206730 Free PMC article.
Echocardiography in Arterial Hypertension.
de Simone G, Mancusi C, Esposito R, De Luca N, Galderisi M. de Simone G, et al. Among authors: esposito r. High Blood Press Cardiovasc Prev. 2018 Jun;25(2):159-166. doi: 10.1007/s40292-018-0259-y. Epub 2018 May 2. High Blood Press Cardiovasc Prev. 2018. PMID: 29721914 Review.
Gut-directed therapy in Parkinson's disease.
Benvenuti L, Di Salvo C, Bellini G, Seguella L, Rettura F, Esposito G, Antonioli L, Ceravolo R, Bernardini N, Pellegrini C, Fornai M. Benvenuti L, et al. Among authors: esposito g. Front Pharmacol. 2024 Jun 21;15:1407925. doi: 10.3389/fphar.2024.1407925. eCollection 2024. Front Pharmacol. 2024. PMID: 38974034 Free PMC article. Review.
Efficacy of a Drug-Eluting Stent Versus Bare Metal Stents for Symptomatic Femoropopliteal Peripheral Artery Disease: Primary Results of the EMINENT Randomized Trial.
Gouëffic Y, Torsello G, Zeller T, Esposito G, Vermassen F, Hausegger KA, Tepe G, Thieme M, Gschwandtner M, Kahlberg A, Schindewolf M, Sapoval M, Diaz-Cartelle J, Stavroulakis K; EMINENT Investigators. Gouëffic Y, et al. Among authors: esposito g. Circulation. 2022 Nov 22;146(21):1564-1576. doi: 10.1161/CIRCULATIONAHA.122.059606. Epub 2022 Oct 18. Circulation. 2022. PMID: 36254728 Free article. Clinical Trial.
736 results